Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Eptifibatide Versus Abciximab in Primary PCI for Acute ST Elevation Myocardial Infarction.

Trial Profile

Eptifibatide Versus Abciximab in Primary PCI for Acute ST Elevation Myocardial Infarction.

Completed
Phase of Trial: Phase III

Latest Information Update: 13 Jul 2012

At a glance

  • Drugs Abciximab; Eptifibatide
  • Indications Embolism and thrombosis; Myocardial infarction
  • Focus Therapeutic Use
  • Acronyms EVA-AMI
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 21 Jun 2010 Actual end date (Dec 2007) added as reported by ClinicalTrials.gov.
    • 27 Apr 2010 Actual patient number (429) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top